Zevra Therapeutics Inc (ZVRA)
8.58
+0.18
(+2.14%)
USD |
NASDAQ |
Nov 04, 13:10
Zevra Therapeutics Profit Margin (Quarterly): -447.9% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -447.9% |
| March 31, 2024 | -485.3% |
| December 31, 2023 | -114.6% |
| September 30, 2023 | -485.1% |
| June 30, 2023 | -30.38% |
| March 31, 2023 | -416.2% |
| December 31, 2022 | |
| September 30, 2022 | -230.2% |
| June 30, 2022 | -1.85K% |
| March 31, 2022 | -47.01% |
| Date | Value |
|---|---|
| December 31, 2021 | -104.7% |
| September 30, 2021 | -89.52% |
| June 30, 2021 | 51.75% |
| March 31, 2021 | -84.97% |
| December 31, 2020 | -205.2% |
| September 30, 2020 | -156.3% |
| June 30, 2020 | 12.43% |
| March 31, 2020 | -275.4% |
| December 31, 2019 | -438.7% |
| September 30, 2019 | 26.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.85K%
Minimum
Jun 2022
51.75%
Maximum
Jun 2021
-299.8%
Average
-180.8%
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -8.95% |
| BioCardia Inc | -54.87K% |
| Xeris Biopharma Holdings Inc | -31.22% |
| Crinetics Pharmaceuticals Inc | -18.56K% |
| Instil Bio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -117.8% |
| Return on Assets | -46.14% |
| Return on Invested Capital | -68.51% |
| Gross Profit Margin (Quarterly) | 19.69% |
| Operating Margin (Quarterly) | -534.8% |
| Return on Net Operating Assets | -100.6% |